A photo of Kasiani Myers.

Kasiani C. Myers, MD

  • Member, Division of Bone Marrow Transplantation and Immune Deficiency
  • Associate Professor, UC Department of Pediatrics



I always wanted to be a physician, and specifically a pediatrician. My father is an adult subspecialist, but I was drawn to the care of medically complex children. Now, I enjoy being the bridge between basic research and the clinic.

In my clinical practice, I specialize in treating patients with bone marrow failure and hematopoietic stem cell transplant for non-malignant diseases, with a special emphasis on Shwachman Diamond syndrome and dyskeratosis congenita. My research interests focus on translational and clinical studies in leukemogenesis and bone marrow failure related to these two conditions. I also study the complications of stem cell transplants, including bronchiolitis obliterans and fertility preservation.

I decided to pursue my research interests after my experience as a resident physician and fellow at Cincinnati Children’s. I enjoyed getting to know my patients on the bone marrow transplant and hematology/oncology units. Plus, I was mentored by two of the world’s foremost experts in the field, Dr. Stella Davies and Dr. Richard Harris, right here at Cincinnati Children’s.

After I completed my postdoctoral training, I joined the faculty of the Division of Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children’s within the UC Department of Pediatrics. Now, in addition to clinical work and research, I serve as the co-director of the North American Shwachman Diamond Syndrome Registry.

BS: University of Michigan, Ann Arbor, MI, 2000.

MD: Case Western Reserve University, Cleveland, OH, 2004.

Post-Doctoral: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010.

Certification: Pediatrics, 2007.

Services and Specialties

Cancer and Blood Diseases, Bone Marrow Transplantation BMT, Fanconi Anemia, Fertility Preservation, Rare Lung Diseases

Research Areas

Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases

Additional Languages

French, Greek

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information


Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors. Knight, TE; Ahn, KW; Hebert, KM; Atshan, R; Wall, DA; Chiengthong, K; Rotz, SJ; Fraint, E; Rangarajan, HG; Auletta, JJ; et al. Transplantation and cellular therapy. 2023.

Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant. Koo, J; Grom-Mansencal, I; Howell, JC; Rios, JM; Mehta, PA; Davies, SM; Myers, KC. Haematologica. 2023.

Pediatric myelofibrosis due to compound heterozygous MPIG6B mutations in a patient of European ancestry. Yenwongfai, LN; Arora, R; Smith, AP; Kalfa, T; Husami, A; Radulescu, V; Myers, K; Lorsbach, R. Pediatric Blood and Cancer. 2023; 70.

Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation. Bender, JD; Oquendo-del Toro, H; Benoit, J; Howell, JC; Badia, P; Davies, SM; Grimley, MS; Jodele, S; Phillips, C; Burns, K; et al. Transplantation and cellular therapy. 2023; 29:130.e1-130.e8.

Using participatory research to identify actionable facilitators and barriers to effective inpatient interdisciplinary communication. Jenkins, AM; Weber, DE; Arfaa, JJ E; Arken, A; Clark, DL; Dobbs, E; Lahbabi, B; Myers, K; Tu, J; Clarke-Myers, K. Journal of hospital medicine (Online). 2023; 18:130-138.

6 Xe Gas-Exchange MRI As a Biomarker to Detect Bronchiolitis Obliterans Syndrome in Children and Young Adults Following Hematopoietic Stem-Cell Transplantation. Plummer, JW; Willmering, M; Towe, C; Myers, K; Walkup, LL. Transplantation and cellular therapy. 2023; 29:s5-s6.

406 All Eyes on Interferon in Graft Failure after Hematopoietic Stem Cell Transplant. Sabulski, DA; Myers, K; Davies, SM; Jodele, S. Transplantation and cellular therapy. 2023; 29:s306-s307.

24 Longitudinal Risk of Bone Disease in a Diverse Pediatric Population Undergoing Allogeneic Hematopoietic Stem Cell Transplant. Sabulski, DA; Segev, N; Hornung, L; Wasserman, H; Myers, K; Howell, JC. Transplantation and cellular therapy. 2023; 29:s20-s21.

Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem. Koo, J; Auletta, JJ; Hartley, DM; Huber, J; Jaglowski, S; Kapadia, M; Kusnier, K; Lehmann, L; Maakaron, J; Myers, KC; et al. Transplantation and cellular therapy. 2022; 28:737-746.

Pediatric 129 Xe Gas-Transfer MRI-Feasibility and Applicability. Willmering, MM; Walkup, LL; Niedbalski, PJ; Wang, H; Wang, Z; Hysinger, EB; Myers, KC; Towe, CT; Driehuys, B; Cleveland, ZI; et al. Journal of Magnetic Resonance Imaging. 2022; 56:1207-1219.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Overall Patient Rating